SUBSCRIBE
SUBSCRIBE
News   FDA

Astellas Pharma Inc. Wins Japan Approval for New Transplant Drug

July 17, 2008 | 
1 min read
TOKYO, July 17 (Reuters) - Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.
FDA Approvals Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Eli Lilly's headquarters in Indianapolis
GLP-1
Lilly Wins Court Battle Against Compounders as Judge Backs FDA: Tirzepatide No Longer in Shortage
May 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Vaccines
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
May 8, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
May 8, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
Weeks Bridge of Harvard University
Job Trends
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
May 7, 2025
 · 
3 min read
 · 
Angela Gabriel